2012

1. Safety, resource use, and quality of life in paramount: A phase III study of maintenance pemetrexed versus placebo after induction pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer

   Journal of Thoracic Oncology, Vol. 7, Núm. 11, pp. 1713-1721